The EMA has approved AstraZeneca’s COVID-19 vaccine for use in the EU in all adults aged over 18
Theories that antibodies affect the placenta are completely unfounded.
Shares of Novavax spiked almost 27% in Thursday’s extended market session after the biotech company announced that its coronavirus vaccine showed to be 89.3% effective against...
The data continues to come in on the various Covid-19 variants, and so far the news is pretty good, according to BioSpace.
How PRISYM 360 streamlined RxSource's labeling The post RxSource optimizes clinical labeling process with PRISYM 360 cloud-based solution appeared first on .
‘Stunning to see with your own eyes,’ says UCLA neuroscientist Martin Monti Credit: Ivy Reynolds In 2016, a team led by UCLA’s Martin Monti reported that...
Much of the attention on Pfizer, BioNTech, Moderna, Johnson & Johnson and AstraZeneca has been on their Covid-19 vaccine efforts, and here is a look at what else...
The hormone acts as a barrier against SARS-CoV-2, blocking the expression of genes that encode proteins in cells serving as viral entry points, according to a...
Credit: Vanderbilt University Medical Center Researchers at Vanderbilt University Medical Center (VUMC) and the University of Texas Medical Branch (UTMB) at Galveston have discovered what may...
In medical research, trust has traditionally been hard-fought for. Terms like “lab rats” and “guinea pigs” are often The post Mistrust in medical research: a patient...
As the largest single-payer healthcare system in Europe, the UK’s National Health Service (NHS) has a uniquely beneficial The post Unlocking health data to improve oncology...
Around 60 million people have had their sense of smell affected by COVID.
From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are The post What we’re expecting in 2021, and...
Novartis has said that its investment in digital technology has helped it to ride out the worst of The post Novartis hails digital strategy as profits...
Merck is stopping development of the company's two Covid-19 vaccine candidates, dubbed V590 and V591, after poor responses in Phase I trials.
The COVID-19 pandemic has added a new layer of complexity to the drug development process. Launch timelines have The post Real-world evidence: breaking boundaries in rare...
Merck & Co. has decided to stop the development of its two COVID-19 vaccine candidates following “inferior” immune responses. Shares slipped about 1% in Monday’s morning...
Two pharmacists involved in COVID-19 vaccine preparation explain the role pharmacists are poised to play in expanding vaccine access.
The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a The post Clinical research in 2021: A new...
With the Pfizer-BioNTech and Moderna Covid-19 vaccines authorized in the United States and being distributed and dosed, some of the attention is shifting to Johnson &...
2020 introduced the term “coronavirus stocks.” These are the companies working on solutions to fend off the Covid-19 global pandemic. As a result, several of the...
Hours after being sworn in as the 46th President of the United States, Joe Biden signed 10 executive orders aimed at combating the ongoing Covid-19 crisis.
Shares of Inovio Pharmaceuticals dropped about 7% after the biotech company priced its $150.5 million share offering.
The new Covid-19 variant identified in South Africa can evade the antibodies that attack it in treatments using blood plasma from previously recovered patients, and may...
The Covid-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus discovered in Britain according to results...
A survey by rare disease patient network Raremark found that 86% of the community members asked were interested The post Unlocking the potential in rare disease...
Credit: ISGlobal/Clínica Universidad de Navarra. A small pilot study suggests that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild...
Measuring mitochondrial DNA could predict who will need ICU care, intubation Credit: WANDY BEATTY One of the most vexing aspects of the COVID-19 pandemic is doctors’...
Credit: Ojeda DS et al., 2021, PLOS Pathogens, CC-BY 4.0 Researchers have developed and applied a robust, versatile antibody test to assist health authorities in managing...
C5 inhibition isn’t the answer to the search for treatments for severe Covid-19 after all. Alexion is pausing enrollment to a Phase III study testing Ultomiris,...